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A b s t r a c t
Background: Studies conducted up to 2010 indicate the underuse of targeted temperature management (TTM) in Poland.
Aim: This study evaluated the current degree of TTM implementation in Polish intensive care units (ICUs) and analysed the 
implementation process since 2010.
Methods: A telephone survey, conducted from December 2014 to July 2015, was carried out to determine the number of 
ICUs using TTM in patients after cardiac arrest. We collected data on the details and prevalence of TTM, and the impact of 
organisational and financial issues and recently published papers on its use.
Results: We obtained data from 271 of 396 ICUs (68.4%). In total, 79 (29.2%) ICUs indicated TTM use and 27 (34.2%) used 
dedicated TTM equipment. Overall, 62% of the ICUs used TTM regardless of the cardiac arrest rhythm. Target temperatures 
of 32–34°C and 34.1–36°C were reached by 44.3% and 43.0% of ICUs, respectively. The duration of TTM was 12–24 h in 
58.2% of the ICUs. The most common barriers to TTM implementation were a lack of dedicated devices (36.3%) and organ-
isational and logistical issues (31.2%). Any influence of recently published data on TTM practice modifications was reported 
by only 23.4% of the ICUs.
Conclusions: Targeted temperature management is underused in Polish ICUs. There is a need for additional educational 
and implementation efforts supporting the translation of knowledge into clinical practice at the regional and national levels.
Key words: survey, therapeutic hypothermia, targeted temperature management, cooling, post-cardiac arrest care, cardiac 
arrest, guidelines implementation
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INTRODUCTION
Every year 350,000 people die in Europe due to cardiac arrest 
[1]. In 2002, two landmark publications showed improved 
neurological outcomes after the introduction of therapeutic 
hypothermia to post-cardiac arrest care [2, 3]. Since 2003 this 
therapy has been recommended by the International Liaison 
Committee on Resuscitation [4], and targeted temperature 
management (TTM) has been implemented as part of re-
suscitation guidelines [5–7]. Despite this recommendation, 
TTM was not promptly adopted as a standard of care in every 
European country [8–10]. Nevertheless, data from Poland 
showed that growing numbers of intensive care units (ICUs) 
were using TTM — from 7.6% of ICUs in 2005 to 21.7% 
in 2010 [11, 12]. The aim of this study was to assess the 
current status of TTM use in Polish ICUs and the changes 
during a five-year period in TTM practices, and to study the 
impact of the results of two recent randomised controlled 
trials (RCTs) on TTM use.
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METHODS 
Using the Polish National Registry of Operators Executing 
Medical Activity database [13], we identified 467 ICUs in 
Poland. From December 2014 to July 2015 we carried out 
a telephone survey, so the survey was conducted before the 
latest European Resuscitation Council 2015 guidelines were 
published [7]. 
Firstly, we contacted the consultant in charge of each ICU. 
In cases where there was no response to our first telephone 
call, we made at least two additional attempts at contact. 
The questionnaire employed in this study was based on an 
instrument used in previous studies [11, 12] and included 
13 questions regarding the prevalence of TTM after cardiac 
arrest regardless its location, the number of patients cooled 
during the previous year, the TTM methodology used, data 
related to cardiac arrest circumstances, and any impact of 
recently published data on current TTM practice.
Statistical significance of differences was analysed using 
the R package v. 3.3.1 (R Foundation for Statistical Comput-
ing, 2016) [14], respectively, with Pearson’s Chi-squared (c2) 
test and Fisher’s exact test (FET). A significance level a of 
0.05 was chosen.
The study protocol was approved by the Ethical 
Committee of Jagiellonian University (approval number: 
KBET/265/B/2014).
RESULTS 
In total, 71 of the identified 467 ICUs were shown not to 
be ICUs treating patients after cardiac arrest; instead, they 
were anaesthesia departments that did not meet the inclu-
sion criteria. We were able to make contact with 340 of the 
remaining 396 ICUs. Despite numerous attempts, we were 
unable to reach 56 ICUs. We obtained data from 271 units, 
representing a 68.4% (271/396) response rate. The main 
reason for missing data was a lack of willingness to participate 
in the study (n = 69). We obtained information by e-mail in 
15 cases because that contact modality was insisted on by 
the staff of those ICUs during the telephone survey (Fig. 1).
The total number of ICUs that declared TTM use was 
79 (29.2%). Figure 2 shows an administrative map of Poland 
and provides percentage values of ICUs using TTM by region. 
Table 1 shows distribution of the study responses in different 
regions of Poland. 
In total, 53.2% of the ICUs declaring TTM use had 
employed the method in more than five patients during the 
previous year. Externally applied, non-invasive measures were 
most commonly used for cooling (e.g. ice bags and cooled 
gels) (43.5%). The use of cold intravenous fluids for induction 
was also common (31.3%). Few of the respondents (6.1%) 
declared using cold fluids for gastric lavage or urinary bladder 
lavage. Dedicated cooling devices, which were either internal 
(n = 8) or external (n = 19), were used by 34.2% of the ICUs 
for the induction and maintenance hypothermia. An alterna-
tive method of cooling reported by one unit involved a renal 
replacement therapy device. In terms of target temperatures, 
the respondents differed somewhat; 44.3% targeted 32–34°C, 
whereas 43.0% aimed at a higher temperature of 34.1–36°C. 
Most of the ICUs (58.2%) maintained TTM for 12–24 h; 
however, 30.4% cooled their patients for more than 24 h. 
The most common location of the temperature probe was in 
the oesophagus (40.0%). The respondents did not use TTM 
for every return of spontaneous circulation patient — 62.0% 
Figure 1. Study flowchart showing the number of intensive 
care units (ICUs) identified and included in the study;  
*Including 15 responses by e-mail
ICUs using TTM < 20%
ICUs using TTM 20–40%
ICUs using TTM > 40%
Figure 2. The percentage of Polish intensive care units (ICUs) 
using targeted temperature management (TTM) after cardiac 
arrest in 2015
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used TTM regardless of the cardiac arrest rhythm, and 27.9% 
used TTM only in cases of cardiac arrest of shockable rhythm 
origin. Pre-hospital usage of TTM was declared by less than 
4% of the respondents.
Almost half of the respondents declaring non-use of 
TTM planned to use it in the future. The most common bar-
riers to implementation were, among other factors, a lack of 
dedicated equipment (36.3%) and financial issues (23.3%); 
however, only 13.9% of the respondents declaring TTM use 
stated that funding provided by the National Healthcare 
System for TTM positively impacted the frequency of its use. 
The questionnaire also inquired about awareness of 
recently published data in the field of TTM (and where this 
could influence medical practice) [15, 16]. Knowledge of these 
data was confirmed by 29.8% of the respondents; however, 
only 23.4% of those who declared TTM use changed their 
practice in response to the published results. Detailed results 
of the survey are presented in Table 2. 
DISCUSSION 
Our study indicates TTM underuse in Polish ICUs. Compared 
with previously published data, our results show that there 
has been progress in the number of Polish units treating their 
patients with TTM (7.6%, 21.7%, and 29.2% of surveyed ICUs 
in 2005, 2010, and 2015, respectively; Fig. 3) [11, 12]. A re-
cently published paper analysing TTM use among Italian ICUs 
also showed TTM underuse [17]; however, the increase in rate 
of TTM use in ICUs in Italy has exceeded that in Poland since 
2005 (increases of 68% and 36.5% per year, respectively). 
Table 3 compares the key elements of TTM in studies 
done in 2010 and 2015 in Poland. Due to the small sample 
size in 2005 it was not included in the analysis (Table 3).
Nevertheless, there have been some changes in the pat-
tern of TTM use among Polish ICUs in the last five years. In 
2010, almost half of Polish ICUs declaring use of TTM were 
treating more than 20 patients per year with TTM, compared 
to only 15% currently (Table 3; c2, p < 0.001). This may have 
an impact on the TTM experience of the staff, and may be 
associated with patient outcome [18].
Currently, the distribution of hospital admissions for car-
diac arrest patients varies among different regions of Poland. 
Poland is one of the leading European countries in terms of 
accessibility to cardiac catheterisation laboratory evaluations 
and continual improvement in patient outcomes [19, 20]. It 
is probable that many cardiac arrest patients (i.e. the potential 
beneficiaries of TTM) are preselected before hospital admis-
sion and transferred directly to cardiac catheterisation labora-
tory evaluation centres in cases of cardiac arrest of obvious 
cardiac origin. Hospital admission in such cases is followed by 
a coronary care unit stay; such units were beyond the scope 
of our study, and this may have decreased the reported actual 
use of TTM in Poland. However, the precise prevalence of 
this type of admission remains unknown. In our study, only 
ICUs staffed by anaesthetists were included.
Table 1. Distribution of the study responses in different regions of Poland
Voivodeship Total number  
of ICUs
Responding  
ICUs
Response  
rate
TTM use:  
number of units
TTM use  
(%)
Lower Silesia 35 25 71% 6 24%
Kuyavia-Pomerania 23 14 61% 2 14%
Lublin 23 15 65% 4 27%
Lubus 14 11 79% 2 18%
Lodz 29 17 59% 7 41%
Lesser Poland 36 24 67% 7 29%
Masovia 48 32 67% 14 44%
Opole 9 7 78% 5 71%
Subcarpathia 23 17 74% 6 35%
Podlasie 13 11 85% 5 45%
Pomerania 16 6 38% 0 0%
Silesia 39 24 62% 5 21%
Holy Cross 11 9 82% 5 56%
Warmia-Masuria 19 12 63% 3 25%
Greater Poland 36 31 86% 5 16%
West Pomerania 22 16 73% 3 19%
ICUs — intensive care units; TTM — targeted temperature management
www.kardiologiapolska.pl
Paweł Krawczyk et al.
692
Table 2. Detailed results of the survey on the use of targeted temperature management in Polish intensive care units;  
*Units could report more than one answer
1. Do you use TTM after ROSC in your unit? Proportion
Yes 29.2% (79/271)
No 70.8% (192/271)
2. How many patients did you cool after ROSC during the last year?
1–5 46.8% (37/79)
6–10 25.3% (20/79)
11–20 12.7% (10/79)
> 20 15.2% (12/79)
3. What methods (internal and/or external) do you use to induce and maintain TTM?*
Internal
Cold intravenous fluids 31.3% (46/147)
Dedicated devices for internal cooling 5.5% (8/147)
Gastric or bladder lavage with cold fluids 6.1% (9/147)
Cold dialysis fluid 0.7% (1/147)
External
Cold packing (ice bags, cooled gels) 43.5% (64/147)
Dedicated devices for external cooling 12.9% (19/147)
4. What is your target temperature during TTM?
30–31.9°C 1.3% (1/79)
32–34°C 44.3% (35/79)
34.1–35.9°C 38.0% (30/79)
36°C 5.0% (4/79)
No control 11.4% (9/79)
5. At what location is the temperature measured during TTM?*
Oesophagus 40.0% (36/90)
Rectum 22.2% (20/90)
Invasive catheter 8.9% (8/90)
Tympanic 6.7% (6/90)
Urinary bladder 7.8% (7/90)
Body surface 5.5% (5/90)
No control 8.9% (8/90)
6. What is the duration of TTM?
< 12 h 11.4% (9/79)
12–24 h 58.2% (46/79)
> 24 h 30.4% (24/79)
7. What cardiac arrest rhythms do you consider when selecting patients for TTM?
All rhythms 62.0% (49/79)
Non-shockable rhythms only (PEA/asystole) 10.1% (8/79)
Shockable rhythms only (VT/VF) 27.9% (22/79)
8. Do you perform pre-hospital TTM?
Yes 3.8% (3/79)
No 96.2% (76/79)
9. Have changes in TTM funding impacted the frequency of your TTM use?
Yes 13.9% (11/79)
No 86.1% (68/79)
Æ
www.kardiologiapolska.pl
Targeted temperature management after cardiac arrest in Polish ICUs. Five years experience
693
differences have also been described in Italy. Our data show 
the regions that should be targeted with respect to improved 
dissemination of post-resuscitation management knowledge 
and awareness of current recommendations. 
Overall, 27 (34.2%) ICUs used dedicated devices provid-
ing either internal (8/79, 10.2%) or external (19/79, 24.0%) 
cooling. This represents a major change compared with 
a 2010 assessment, during which no ICU declared use of equip-
ment for internal cooling and only 9% (5/57) used dedicated 
external TTM devices (Table 3; c2, p < 0.001). However, 34.2% 
remains a very low proportion when compared with recently 
published studies from Italy or Germany that demonstrated the 
use of dedicated TTM equipment in 75% and 78% of cases, 
respectively [17, 21]. The most popular methods of cooling in 
Polish ICUs are cold intravenous fluids for induction and ice 
packs for maintenance. Similar to the Italian study [17], 36% 
of our respondents cited lack of equipment as the reason for 
not using TTM. There is no contraindication for using TTM 
without specific equipment; despite more precise temperature 
control, reduced latency in reaching the target temperature 
(when 32–34°C is chosen as the target), and less nursing staff 
workload, there is no evidence of better patient outcomes when 
using dedicated equipment [22, 23].
Our analysis of the reasons for not cooling patients 
showed similar results to a previous study (lack of protocols, 
equipment, and experience, and problems with funding) 
[12]. In 2014, the Polish National Healthcare System started 
Figure 3. The percentage of Polish intensive care units (ICUs) 
using targeted temperature management (TTM) in 2005–2015
10. Are you aware of studies that have assessed the efficacy of TTM (i.e. Kim et al. [16] and Nielsen et al. [15]
Yes 29.8% (77/258)
No 70.2% (181/258)
11. If yes, did those articles influence your practice?
Yes 23.4% (18/77)
Stopped using TTM (1/18)
TTM with 36°C instead of 32–34°C (17/18)
No 76.6% (59/77)
12. If you do not use TTM, have you considered implementing the procedure?
Yes 43.6% (82/188)
No 56.4% (106/188)
13. If you do not use TTM, what are the reasons for this?*
No equipment 36.3% (114/314)
Financial problems 23.3% (73/314)
Lack of experience 19.1% (60/314)
Lack of knowledge, standards 12.1% (38/314)
Other 7.6% (24/314)
Another department is responsible for therapeutic hypothermia 1.6% (5/314)
PEA — pulseless electrical activity; ROSC — return of spontaneous circulation; VF/VT — ventricular fibrillation/ventricular tachycardia
Table 2. cont. Detailed results of the survey on the use of targeted temperature management in Polish intensive care units;  
*Units could report more than one answer
In our study, the distribution of TTM sites in Poland also 
differed compared to a previous study [12]. In the majority 
of regions, TTM use had increased. However, there was an 
unequal distribution of ICUs using TTM within the country, 
with greater TTM use in central and eastern Poland; regional 
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Table 3. Comparison of the key targeted temperature management (TTM) elements found in the 2010 and 2015 studies.  
Due to the small sample size of the 2005 study, it was not included
Question Answer 2010 2015 Test p
1. Do you use TTM after ROSC in your units? Yes 
No
57 (22%) 
206 (78%)
79 (29%) 
192 (71%)
Chi2 0.047
2. How many patients did you cool after ROSC 
during the last year?
< 20 
> 20
32 (56%) 
25 (44%)
67 (85%) 
12 (15%)
Chi2 < 0.001
3. Do you use dedicated devices  
for cooling?
Device 
No device
5 (9%) 
52 (91%)
27 (34%) 
52 (66%)
Chi2 < 0.001
4. What is your target temperature  
during TTM?
32–34oC 
> 34oC
37 (65%) 
20 (35%)
35 (51%) 
34 (49%)
Chi2 0.11
6. What is the duration of TTM? < 12 h 
12–24 h 
> 24 h
6 (11%) 
36 (63%) 
15 (26%)
9 (11%) 
46 (58%) 
24 (30%)
Chi2 0.84
7. Do you consider all cardiac arrest rhythms 
when selecting patients for TTM?
All rhythms 
VF/VT
55 (98%) 
1 (2%)
49 (69%) 
22 (31%)
FET < 0.001
8. Do you perform pre-hospital TTM? Yes 
No
2 (4%) 
55 (96%)
3 (4%) 
76 (96%)
FET 1
FET — Fisher’s exact test; ROSC — return of spontaneous circulation; VF/VT — ventricular fibrillation/ventricular tachycardia
to reimburse ICUs for the use of TTM. The economic aspects 
associated with introducing TTM have been discussed in other 
studies; however, in those studies, cost appeared also to not 
represent a major barrier to use [17]. 
Other reasons indicated in previous studies for ICUs not 
using TTM include a lack of ready-to-use protocols and a lack 
of strong evidence of the effectiveness of TTM from prospec-
tive, high-quality RCTs. Therefore, some clinicians remain 
unconvinced regarding the use of TTM in all cardiac arrest pa-
tients. This issue has been previously discussed elsewhere [24]. 
The recently updated Cochrane review on hypothermia for 
neuroprotection in adults after cardiopulmonary resuscitation, 
comparing conventional cooling versus no cooling, revealed 
a greater likelihood of reaching a favourable neurological 
outcome and survival benefit with cooling; however, it was 
also connected with increased incidence of pneumonia and 
hypokalaemia [25]. A recently published systematic review 
also indicated improved survival and neuroprotective benefit 
when exploring the impact of expended criteria and targeted 
temperature but did not find evidence to support one specific 
temperature over another [26]. 
Returning to the results of our study, we noted a risk of 
ICU staff misinterpreting recently published data. The study 
respondents were asked if they were aware of the results of 
the TTM trial [15]; only 29.8% declared familiarity with that 
trial, and some of them interpreted the results as supporting 
their hesitancy to use TTM. We identified at least one unit in 
which clinicians stopped using TTM because they misinter-
preted the results of this previous trial. This is a current topic 
of discussion in the literature; misinterpretation of data creates 
the risk of TTM not being used, which may in turn influence 
patient outcomes [27]. Only 23.4% of our respondents with 
knowledge of the previous TTM trial [15] implemented the 
new evidence in their clinical practice with respect to current 
target temperature guidelines (32–34°C and 36°C). A recent 
study of the influence of the TTM trial on the clinical prac-
tice of 264 ICUs in 11 countries showed that only 37% of 
the participating physicians declared changing any aspect of 
their practice [28]. This may be due to a generally low rate of 
translation of knowledge into clinical practice, and to a lack of 
strong published evidence on certain aspects of TTM. 
Targeted temperature management use prior to hospitali-
sation is uncommon in Poland, being reported by only a few 
ICUs. The frequency of pre-hospital TTM use over the last 
10 years has remained steady in Poland, with approximately 
4% of units reporting this type of treatment [11, 12] (Table 3; 
FET, p = 1). The therapeutic window for introducing TTM is 
up to 240 min [22]. Some studies indicate a potential benefit 
from early cooling [29]. However, recently published data by 
Kim et al. [16] did not demonstrate a significant difference 
in patient outcome when cold fluid infusion was introduced 
early. According to evidence coming from systematic review 
and meta-analysis on pre-hospital induction of hypothermia 
with cold fluid infusion, the patients had lower temperature 
at hospital admission without other benefits in survival and 
neurological outcome. The results indicate also increased in-
cidence of rearrests, but there was no increase in pulmonary 
oedema rate reported in some studies [30]. 
Limitations of the study
One limitation of our study is the number of respondents; 
despite multiple attempts, we were unable to make contact 
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with all of the ICUs. The refusal rate was 17.4% (69/396); 
despite this, we managed to reach a response rate of 68.4%, 
with only one region having lower response rate, as shown in 
Table 1. Issues cited by the respondents included the fact that 
the survey had to be completed during working hours, as well 
as difficulties in maintaining telephone contact with personnel 
on active duty. However, we considered this mode of contact 
to be optimal for ensuring a high response rate compared to 
other methods (e.g. e-mail and postal mail correspondence). 
Nevertheless, telephone contact may also create bias although 
the respondents were consultant physicians in charge of the 
unit on the day of the call, such that the results should have 
been representative of the overall ICU. Finally, we did not 
collect additional information on post-cardiac arrest care 
(e.g. regarding the presence or absence of written standard 
operating procedures for treatment and prognosis, target 
haemodynamic values, and the use of ventilation, coronary 
interventions, and drugs), which may hinder full understanding 
of standard post-cardiac arrest care in Polish ICUs. However, 
this study aimed to specifically assess TTM use.
CONCLUSIONS
Based on the observations presented above, we conclude 
that despite an increase in the number of ICUs in Poland 
using TTM the method remains underused. There are no 
financial barriers to TTM implementation; instead, the 
major limitations include a persistent lack of national and 
regional standard TTM protocols, misunderstanding or 
misinterpretation of published evidence, and a lack of 
unequivocal data on TTM efficacy, which may influence 
current practice and patient outcomes. There is a need 
for increased educational and implementation efforts, to 
ensure clinical practice compliance with the guidelines at 
the national and regional levels to enhance the recovery 
of patients after cardiac arrest.
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Implementacja kontroli temperatury docelowej 
po zatrzymaniu krążenia na polskich oddziałach 
intensywnej terapii. Co się zmieniło w ciągu  
ostatnich 5 lat?
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S t r e s z c z e n i e
Wstęp: Przeprowadzone do 2010 r. prace naukowe wskazują na niedostateczne stosowanie kontroli temperatury docelowej 
w Polsce.
Cel: Celem pracy była ocena częstości stosowania kontroli temperatury docelowej na polskich oddziałach anestezjologii 
i intensywnej terapii (OAiIT) i analiza procesu implementacji od 2010 r.
Metody: Od grudnia 2014 do lipca 2015 r. przeprowadzono ankietę telefoniczną, aby ocenić liczbę OAiIT w Polsce stosu-
jących kontrolę temperatury docelowej u pacjentów po zatrzymaniu krążenia. Zbierano szczegółowe dane dotyczące samej 
procedury oraz wpływu zmian organizacyjnych, ostatnio opublikowanych dowodów naukowych na zastosowanie tej terapii.
Wyniki: Uzyskano dane z 271 spośród 396 (68,4%) OAiIT. Stosowanie kontroli temperatury docelowej zadeklarowało 
79 (29,2%) OAiIT, a 27 (34,2%) z nich stosowało w tym celu dedykowany sprzęt. W 62% OAiIT stosowano kontrolę tem-
peratury docelowej niezależnie od mechanizmu zatrzymania krążenia. Temperatury docelowe 32–34°C i 34,1–36°C były 
stosowane odpowiednio w 44,3% oraz 43,0% OAiIT. Czas trwania procedury wynosił 12–24 godzin w przypadku 58,2% 
OAiIT. Najczęstsze bariery stanowił brak sprzętu (36,3%) oraz kwestie organizacyjne i logistyczne (31,2%). Jedynie 23,4% 
OAiIT zgłosiło modyfikacje w postępowaniu wynikające z niedawno opublikowanych danych.
Wnioski: Kontrola temperatury docelowej jest nadal rzadko stosowana na polskich OAiIT. Istnieje duża potrzeba działań 
edukacyjnych w celu poprawy implementacji wytycznych w tym zakresie na poziomie regionalnym i krajowym.
Słowa kluczowe: ankieta, hipotermia terapeutyczna, kontrola temperatury docelowej, opieka poresuscytacyjna, zatrzymanie 
krążenia, Implementacja wytycznych
Kardiol Pol 2017; 75, 7: 689–697
